Heart failure (HF) is a global pandemic affecting 64 million people worldwide. HF with
preserved ejection fraction (HFpEF) has traditionally received less attention than its main …

Aims Heart failure (HF) is a chronic and progressive syndrome associated with a poor
prognosis. While it may seem intuitive that the risk of adverse outcomes varies across the …

Aims Limited data on the uptake of guideline‐directed medical therapies (GDMTs) and the
mortality of acute decompensated HF (ADHF) patients are available from India. The National …

Aims Sex differences in the long-term prognosis of heart failure (HF) remain controversial,
and there is a lack of comprehensive pooling of the sex differences in outcomes of HF. This …

Heart failure remains a health challenge in Africa, associated with significant rates of
hospitalization, morbidity and mortality. The current review aims to summarize the most …

Although epidemiological data on heart failure (HF) with preserved ejection fraction (HFpEF)
are scarce in the Middle East, North Africa and Turkey (MENAT) region, Lancet Global …

Background Heart failure with reduced ejection fraction (HFrEF) is a prevalent
cardiovascular disease globally, posing a significant burden on healthcare and society. Left …

Background Current predictive models based on biomarkers reflective of different pathways
of heart failure with reduced ejection fraction (HFrEF) pathogenesis constitute a useful tool …

Aims Currently, little evidence exists on survival and quality of care in cancer patients
presenting with acute heart failure (HF). The aim of the study is to investigate the …

Despite significant advances in the management of heart failure (HF), further improvement in
the outcome of this chronic and progressive disease is still considered a major unmet need …